Trial record 1 of 1 for:
RD.06.SPR.204358
To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus (NemoCKDaP)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05075408 |
Recruitment Status :
Completed
First Posted : October 12, 2021
Last Update Posted : April 9, 2024
|
Sponsor:
Galderma R&D
Information provided by (Responsible Party):
Galderma R&D
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | January 3, 2024 |
Actual Study Completion Date : | January 3, 2024 |